Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Filings indexed 370 across all filing types
Latest filing 2024-11-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Jeonjin BioPharm Co., Ltd. for the period ending September 30, 2024. It contains detailed financial data, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
[기재정정]소송등의제기ㆍ신청(경영권분쟁소송) (임시총회소집허가)
Legal Proceedings Report Classification · 1% confidence The document is a formal regulatory filing regarding a legal proceeding ('소송 등의 제기ㆍ신청') specifically concerning a management dispute ('경영권 분쟁 소송') and a request for permission to convene an extraordinary general meeting. It details the court case, the parties involved, and the specific agenda items for the proposed meeting. As this pertains to legal proceedings and litigation involving the company, it falls under the 'Legal Proceedings Report' category.
2024-11-12 Korean
소송등의제기ㆍ신청(경영권분쟁소송) (임시총회소집허가)
Legal Proceedings Report Classification · 1% confidence The document is a formal disclosure regarding a legal proceeding ('소송 등의 제기ㆍ신청') specifically concerning a management dispute ('경영권 분쟁 소송') and a request for permission to convene an extraordinary general meeting ('임시총회소집허가'). This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2024-09-04 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for '전진바이오팜 주식회사' covering the period from January 1, 2024, to June 30, 2024. It contains detailed corporate information, financial data, and management disclosures required for a formal interim filing in South Korea. As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2024
2024-08-13 Korean
불성실공시법인지정 (공시번복 5건, 공시불이행 1건)
Regulatory Filings Classification · 1% confidence The document is an official notice from the Korea Exchange (KRX) regarding the designation of 'Jeonjin BioPharm' as an 'Unfaithful Disclosure Corporation' (불성실공시법인지정) due to disclosure violations (failures and reversals). This is a regulatory announcement concerning compliance and penalties, which falls under the 'Regulatory Filings' category as it does not fit into specific financial reporting or corporate action categories.
2024-08-05 Korean
주권매매거래정지 (불성실공시법인 지정)
Delisting Announcement Classification · 1% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for '전진바이오팜(주)' due to being designated as an unfaithful disclosure corporation. It cites specific KOSDAQ market regulations. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2024-08-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.